Our work demonstrates that caspase-3 loss sensitizes colon cancer cells to genotoxic agents by promoting RIP1-, pro-caspase-8-, and ROS-dependent necrosis, without blocking apoptosis (Supplementary Figure S7C). Here, CASP3 is linked to malignant colon neoplasm.